Igal Louria-Hayon
Technik-/Wissenschafts-/F&E-Leiter bei RAPHAEL PHARMACEUTICAL INC.
Vermögen: 2 Mio $ am 31.05.2024
Profil
Igal Louria-Hayon is currently the Scientific Director-Medical Cannabis Research at Rambam Health Care Campus and the Director & Chief Technology Officer at Raphael Pharmaceutical, Inc. He previously worked as the Chief Technology Officer & Chief Scientist at Easy Energy, Inc. and as the Head-Leukemia & Immunotherapy Research Laboratory at Clinical Research Institute (Israel).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.05.2024 | 999 000 ( 5,35% ) | 2 Mio $ | 31.05.2024 |
Aktive Positionen von Igal Louria-Hayon
| Unternehmen | Position | Beginn |
|---|---|---|
| RAPHAEL PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.09.2021 |
| Rambam Health Care Campus | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Igal Louria-Hayon
| Unternehmen | Position | Ende |
|---|---|---|
| Clinical Research Institute (Israel) | Corporate Officer/Principal | - |
Easy Energy, Inc.
 Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RAPHAEL PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Easy Energy, Inc.
Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel. | Electronic Technology |
| Rambam Health Care Campus | |
| Clinical Research Institute (Israel) |
